Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: bluejeans who wrote (23804)	8/3/1998 8:38:00 AM
From: Henry Niman	Read Replies (2) \| Respond to of 32384

Thanks for the heads up on the article: paradise-web.com I had heard that some of the institutions were abandoning some of the smaller Biotechs and it looks like the T Rowe Price Health Science fund participated.

To: bluejeans who wrote (23804)	8/3/1998 9:44:00 AM
From: Mudcat	Respond to of 32384

I can't understand why they would want to sell a stock priced at around 11, that according to this thread is cheap even at 20, and has the best pipeline in the industry. Can you explain Bluejeans. Hey maybe they sold all the others and kept or are even buying more Ligand. Could this be a plot by T Rowe Price to get the stock price of biotechs down so they can buy Ligand at a cheap price. Sounds like a case for the cybersleuths. LOL